830,000 Covid-19 cases treated under Ayushman Bharat in 2 years: Govt

Approximately 8.3 lakh hospital admissions were authorised for the treatment of COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in the last two years, the RS was informed

830,000 Covid-19 cases treated under Ayushman Bharat in 2 years: Govt

Press Trust of India New Delhi
Approximately 8.3 lakh hospital admissions were authorised for the treatment of COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in the last two years, the Rajya Sabha was informed on Tuesday.
"This is with respect to transactions recorded on the NHA (National Health Authority) IT platform as well as the information shared by states, using their own IT systems," Minister of State for Health Bharati Pravin Pawar said in a written reply to a question in the House.
Out of these 8.3 lakh, approximately 4.7 lakh have been authorised in empanelled private hospitals under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), she said.
Benefits of the scheme are portable across the country, therefore, urban-rural bifurcation is not maintained for the beneficiaries, she stated.
Public Health being a state subject, response to the COVID-19 pandemic is primarily directed by state governments, she said, adding the National Health Authority has been providing necessary support to states and UTs for ensuring free COVID-19 testing and treatment to all eligible beneficiaries under AB-PMJAY.
When COVID-19 pandemic started, initially existing treatment packages were used for providing Covid-related treatment. Later, special packages were introduced, she explained.
Many state governments decided to make COVID-19 testing and treatment free for all residents. While some of them used Ayushman Bharat PMJAY ecosystem including the NHA's IT platform, others used their own IT systems. Therefore, COVID-19 treatments have been captured in both general and COVID-19 specific packages of AB-PMJAY, Pawar said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 30 2021 | 6:28 PM IST

Explore News